Our main motivation for signing up for the Johnson & Johnson case competition was because of the challenge it posed. Pharma-economics is a challenging, highly complex industry, and we knew it would require an incredible amount of hard work and research. Despite knowing this, we wanted to push our limits and expand our knowledge of this sector.
The harder the challenge, the more rewarding the end result, so we went for it with everything we had.
The project was about creating a market access strategy in EMEA for the launch of a severe respiratory disease treatment drug. Additionally, we were posed with the question to optimally transfer this solution to emerging markets. Read the rest of this entry »